Sphera Funds Management Ltd. Nurix Therapeutics, Inc. Transaction History

Sphera Funds Management Ltd.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$22.71 - $36.69 $5.54 Million - $8.96 Million	-244,157 Closed	0 $0
Q2 2021 Aug 17, 2021	BUY	$24.21 - $35.89 $704,051 - $1.04 Million	29,081 Added 13.52%	244,157 $6.48 Million
Q1 2021 May 17, 2021	BUY	$26.98 - $50.17 $5.8 Million - $10.8 Million	215,076 New	215,076 $6.69 Million
Q4 2020 Feb 16, 2021	SELL	$22.85 - $48.44 $513,668 - $1.09 Million	-22,480 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$16.05 - $34.91 $360,804 - $784,776	22,480 New	22,480 $785,000

180

68.1M

78K

53.8K

Ticker NRIX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,147,800
Market Cap $940M
Description
Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapies for the treatment of cancer and immune disorders. The company develops NX-2127, an orally available Bruton's tyrosine kinase (BTK) degrader for the treatment of relapsed or refractory B-cell malignancies...

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

Stay updated on Sphera Funds Management Ltd. with notifications on news.